HomeHOWL • NASDAQ
add
Werewolf Therapeutics Inc
Previous close
$1.07
Day range
$1.04 - $1.11
Year range
$0.60 - $2.38
Market cap
53.15M USD
Avg Volume
627.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.86M | -11.31% |
Net income | -16.37M | 1.82% |
Net profit margin | — | — |
Earnings per share | -0.36 | 5.26% |
EBITDA | -15.32M | 8.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.71M | -46.50% |
Total assets | 79.63M | -43.14% |
Total liabilities | 50.01M | -1.27% |
Total equity | 29.61M | — |
Shares outstanding | 48.54M | — |
Price to book | 1.70 | — |
Return on assets | -45.66% | — |
Return on capital | -54.03% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -16.37M | 1.82% |
Cash from operations | -15.16M | -21.62% |
Cash from investing | — | — |
Cash from financing | 3.27M | 54,666.67% |
Net change in cash | -11.88M | 4.72% |
Free cash flow | -9.87M | -30.45% |
About
Founded
2017
Headquarters
Website
Employees
39
